Q1 2026 turned out to be my second worst quarter since 2022, with a -14.5% return.
With many names down 30% in just one month, it was hard to do much better. My exposure to healthcare partially protected part of the portfolio.
Given the numerous opportunities, I preferred to rotate that part of the healthcare allocation into more offensive stocks in order to take advantage of the current discounts.
I’m extremely confident in my allocation and, based on my fair value estimates, I believe the portfolio can deliver a 24% CAGR over the next five years, a number from which a large part of my conviction comes.
For SG users only, Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with unlimited trading on SG, HK, and US stocks, as well as ETFs.
🎉Cash Boost Account Now Supports 35,000+ Stocks & ETFs – Greater Flexibility Now
Find out more here.
Complete your first Cash Boost Account trade with a trade amount of ≥ SGD1000* to get SGD 688 stock vouchers*! The trade can be executed using any payment type available under the Cash Boost Account: Cash, CPF, SRS, or CDP.
Other helpful links:
Comments